Viewing StudyNCT03610516



Ignite Creation Date: 2024-05-06 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 12:50 PM
Study NCT ID: NCT03610516
Status: COMPLETED
Last Update Posted: 2023-07-28
First Post: 2018-06-01

Brief Title: Safety Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis
Sponsor:
Organization: Novartis

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 57
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: